We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-6 of 6

Homeopathy plus! Not immune from the ACL

  • King & Wood Mallesons
  • -
  • Australia
  • -
  • March 7 2013

On 21 February 2013, the ACCC instituted proceedings against Homeopathy Plus! Australia Pty Ltd ("Homeopathy Plus!") in the Federal Court of

Vioxx class action: special leave refused

  • King & Wood Mallesons
  • -
  • Australia
  • -
  • July 10 2012

On 15 May 2012 the High Court refused special leave to appeal from the decision of the Full Federal Court to refuse to award damages in the Vioxx class action

Special leave to appeal refused in the VIOXX class action

  • King & Wood Mallesons
  • -
  • Australia
  • -
  • July 5 2012

The High Court of Australia has refused special leave to appeal from the full court of the Federal Court of Australia in the VIOXX class action

Federal Court prescribes hard medicine for Vioxx class action

  • King & Wood Mallesons
  • -
  • Australia
  • -
  • March 15 2012

The full court of the Federal Court of Australia recently overturned a damages award in the VIOXX class action, confirming once again that issues of causation are no less difficult to prove in large-scale class actions than in individual proceedings

TGA gets tough on sponsors who fail to comply with advertising rules

  • King & Wood Mallesons
  • -
  • Australia
  • -
  • August 11 2011

The TGA may now publicise a failure to comply with advertising rules for therapeutic goods

Australia and New Zealand move closer to joint regulation of medicines and medical devices

  • King & Wood Mallesons
  • -
  • Australia, New Zealand
  • -
  • June 23 2011

On Monday, the Prime Minster Julia Gillard, and her New Zealand counterpart John Key, announced that both countries had signed a statement of intent to create a joint authority to regulate medicines and medical devices in both countries